
Releases
KROMATID Appoints Matthew Hemstreet as CEO to Drive Market Expansion
Boulder-based genomic analysis firm KROMATID has named Matthew Hemstreet as its new Chief Executive Officer. Hemstreet, previously the company’s Vice President of Global Marketing, takes the helm from Terry Opgenorth to steer the organization through its next phase of growth in the cell and gene therapy sector.























